Projected Income Statement: Virbac

Forecast Balance Sheet: Virbac

Forecast Balance Sheet - Virbac
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 -73.8 -79.4 -52.4 169 173 108 39.6 -53.3
Change - -7.59% 34.01% 422.52% 2.37% -37.5% -63.33% -234.6%
Announcement Date 22/3/22 23/3/23 19/3/24 13/3/25 17/3/26 - - -
1EUR in Million
Estimates

Cash Flow Forecast: Virbac

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 33.65 53.58 59.9 80.44 92.24 122.9 116.6 113.9
Change - 59.21% 11.8% 34.29% 14.67% 33.26% -5.11% -2.31%
Free Cash Flow (FCF) 1 96.25 45.41 58.74 123.8 106.8 88.27 121.7 149.2
Change - -52.82% 29.36% 110.73% -13.76% -17.32% 37.86% 22.6%
Announcement Date 22/3/22 23/3/23 19/3/24 13/3/25 17/3/26 - - -
1EUR in Million
Estimates

Forecast Financial Ratios: Virbac

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 20.21% 18.37% 18.67% 20.25% 19.76% 20.49% 21.36% 22.06%
EBIT Margin (%) 15.87% 15.03% 14.83% 16.28% 15.68% 16.64% 17.34% 17.95%
EBT Margin (%) 14.95% 14.51% 13.97% 14.87% 14.85% 16.07% 17.17% 18.05%
Net margin (%) 10.64% 10.03% 9.73% 10.4% 10.3% 11.12% 11.69% 12.17%
FCF margin (%) 9.05% 3.73% 4.71% 8.86% 7.29% 5.67% 7.38% 8.59%
FCF / Net Income (%) 85.03% 37.22% 48.43% 85.2% 70.75% 50.97% 63.09% 70.55%

Profitability

        
ROA - 9.62% 8.7% 8.79% 8.02% 8.3% 8.2% 8.3%
ROE 16.82% 15.59% 13.94% 14.95% 13.92% 14.09% 13.64% 12.85%

Financial Health

        
Leverage (Debt/EBITDA) - - - 0.6x 0.6x 0.34x 0.11x -
Debt / Free cash flow - - - 1.36x 1.62x 1.23x 0.33x -

Capital Intensity

        
CAPEX / Current Assets (%) 3.16% 4.41% 4.8% 5.76% 6.3% 7.9% 7.07% 6.56%
CAPEX / EBITDA (%) 15.65% 23.99% 25.73% 28.42% 31.86% 38.54% 33.1% 29.72%
CAPEX / FCF (%) 34.96% 117.99% 101.98% 64.98% 86.4% 139.26% 95.85% 76.37%

Items per share

        
Cash flow per share 1 15.38 11.71 14.06 24.37 23.73 30.32 33.16 36.17
Change - -23.86% 20.09% 73.31% -2.61% 27.73% 9.37% 9.09%
Dividend per Share 1 1.25 1.32 1.32 1.45 1.45 1.724 2.041 2.382
Change - 5.6% 0% 9.85% 0% 18.88% 18.42% 16.68%
Book Value Per Share 1 85.82 99.42 107.6 124.6 134.3 153.7 174.1 199.5
Change - 15.85% 8.2% 15.79% 7.83% 14.46% 13.27% 14.56%
EPS 1 13.4 14.43 14.38 17.34 18 20.67 22.88 25.01
Change - 7.69% -0.35% 20.58% 3.81% 14.83% 10.67% 9.34%
Nbr of stocks (in thousands) 8,443 8,451 8,443 8,375 8,378 8,382 8,382 8,382
Announcement Date 22/3/22 23/3/23 19/3/24 13/3/25 17/3/26 - - -
1EUR
Estimates
2026 *2027 *
P/E 16.8x 15.2x
PBR 2.26x 1.99x
EV / Sales 1.94x 1.79x
Yield 0.5% 0.59%

EPS & Dividend

EPS & Dividend - Virbac


Y-o-Y evolution of P/E

Valuation ratios - P/E - Virbac
 

Year-on-year evolution of the Yield

Valuation ratios - Yield - Virbac
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Virbac
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
347.00EUR
Average target price
410.75EUR
Spread / Average Target
+18.37%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Virbac